Articles related to BIPOLAR DISORDER

Cannabis use at psychiatric admission was associated with a higher risk of early rehospitalization among young adults hospitalized for bipolar or psychotic disorders, although the association weakened over time and was no longer statistically significant by six months.

Semaglutide use was associated with lower psychiatric hospitalization and bipolar-relapse hospitalization risks among Swedish adults with bipolar disorder receiving antidiabetic medication, although the observational findings did not establish a therapeutic effect.

The FDA granted Fast Track designation to elunetirom, an oral CNS thyroid hormone receptor agonist, for adjunctive treatment of bipolar depression, while the agent remains in a 30-participant open-label phase 2 trial with no human efficacy data yet available.

A middle-aged woman with a four-year bipolar disorder diagnosis continued deteriorating despite psychiatric treatment until clinical reassessment pointed toward anti-NMDA receptor encephalitis, an autoimmune condition whose psychiatric prodrome frequently delays correct diagnosis.

A Rhode Island court denied summary judgment in an informed consent suit after a patient developed permanent tardive dyskinesia following an intra-class antipsychotic switch.

A meta-analysis of 285 studies found lifetime psychosis in over half of patients with bipolar disorder and comorbid schizophrenia in 8%, with substantial differences between bipolar I and bipolar II subtypes.